| 000 | 04128nam a22005775i 4500 | ||
|---|---|---|---|
| 001 | 978-981-97-7568-2 | ||
| 003 | DE-He213 | ||
| 005 | 20251030113314.0 | ||
| 007 | cr nn 008mamaa | ||
| 008 | 241115s2024 si | s |||| 0|eng d | ||
| 020 |
_a9789819775682 _9978-981-97-7568-2 |
||
| 024 | 7 |
_a10.1007/978-981-97-7568-2 _2doi |
|
| 050 | 4 | _aRM300-666 | |
| 072 | 7 |
_aMMG _2bicssc |
|
| 072 | 7 |
_aMED071000 _2bisacsh |
|
| 072 | 7 |
_aMKG _2thema |
|
| 245 | 1 | 0 |
_aSodium-glucose Cotransporter-2 (SGLT2) Inhibitors in Heart Failure _h[electronic resource] : _bMechanisms and Clinical Applications: A Machine-Generated Literature Overview / _cedited by Mukesh Nandave. |
| 250 | _a1st ed. 2024. | ||
| 264 | 1 |
_aSingapore : _bSpringer Nature Singapore : _bImprint: Springer, _c2024. |
|
| 300 |
_aXIV, 528 p. 10 illus., 9 illus. in color. _bonline resource. |
||
| 336 |
_atext _btxt _2rdacontent |
||
| 337 |
_acomputer _bc _2rdamedia |
||
| 338 |
_aonline resource _bcr _2rdacarrier |
||
| 347 |
_atext file _bPDF _2rda |
||
| 505 | 0 | _aChapter 1_ The History of the Development of Sodium-glucose Cotransporter-2 (SGLT2) Inhibitors for the Treatment of Diabetes: from biology to Chemistry -- Chapter 2_ Sodium-glucose Cotransporter-2 (SGLT2) inhibitors and mechanism of cardiovascular benefits in type 2 diabetes -- Chapter 3_ Sodium-glucose Cotransporter-2 (SGLT2) inhibitors for primary and secondary protection from cardiovascular and renal diseases in Type 2 diabetes -- Chapter 4_ Sodium-glucose Cotransporter-2 (SGLT2) inhibitors: Emerging opportunities for the treatment of myocardial infarction -- Chapter 5_ Potential Role of Sodium-glucose Cotransporter-2 (SGLT2) Inhibitors in the Treatment and Prevention of Diabetic Cardiomyopathy -- Chapter 6_ Contemporary Management, unmet needs, and Therapeutic Potential of Sodium-glucose Cotransporter-2 (SGLT2) Inhibitors in congestive heart failure -- Chapter 7 A comprehensive review of preclinical and clinical information on the cardiovascular advantages of Sodium-glucose Cotransporter-2 (SGLT2) inhibitors -- Chapter 8_ Exploring the current selective drugs of Sodium-glucose Cotransporter-2 (SGLT2) inhibitors for the treatment of cardiovascular disease in Type 2 Diabetes -- Chapter 9_ A comprehensive review of Sodium-glucose Cotransporter-2 (SGLT2) inhibitor’s effects on cardiovascular events, mortality, and significant safety outcomes in individuals with type 2 diabetes. | |
| 520 | _aThe auto-summaries have been generated by a recursive clustering algorithm via the Dimensions Auto-summarizer by Digital Science handled by Subject Matter Experts and the editor(s) of this book. The editor(s) of this book selected which SN content should be auto-summarized and decided its order of appearance. Please be aware that these are extractive auto-summaries, which consist of original sentences, but are not representative of its original paper, since we do not show the full length of the publication. Please note that only published SN content is represented here, and that machine-generated books are still at an experimental stage. | ||
| 650 | 0 |
_aPharmacology. _967844 |
|
| 650 | 0 |
_aMedicine _xResearch. _962598 |
|
| 650 | 0 |
_aBiology _xResearch. _965629 |
|
| 650 | 0 |
_aPharmacovigilance. _974275 |
|
| 650 | 0 |
_aMedicine. _963923 |
|
| 650 | 0 |
_aCardiology. _975410 |
|
| 650 | 1 | 4 |
_aPharmacology. _967844 |
| 650 | 2 | 4 |
_aBiomedical Research. _965633 |
| 650 | 2 | 4 |
_aDrug Safety and Pharmacovigilance. _974276 |
| 650 | 2 | 4 | _aClinical Medicine. |
| 650 | 2 | 4 |
_aCardiology. _975410 |
| 700 | 1 |
_aNandave, Mukesh. _eeditor. _4edt _4http://id.loc.gov/vocabulary/relators/edt _974724 |
|
| 710 | 2 | _aSpringerLink (Online service) | |
| 773 | 0 | _tSpringer Nature eBook | |
| 776 | 0 | 8 |
_iPrinted edition: _z9789819775675 |
| 776 | 0 | 8 |
_iPrinted edition: _z9789819775699 |
| 776 | 0 | 8 |
_iPrinted edition: _z9789819775705 |
| 856 | 4 | 0 | _uhttps://doi.org/10.1007/978-981-97-7568-2 |
| 912 | _aZDB-2-SME | ||
| 912 | _aZDB-2-SXM | ||
| 999 |
_c64975 _d64975 |
||